We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Diaceutics Plc | LSE:DXRX | London | Ordinary Share | GB00BJQTGV64 | ORD GBP0.002 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 104.00 | 102.00 | 106.00 | 104.00 | 103.00 | 104.00 | 33,678 | 08:00:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Testing Laboratories | 19.5M | 724k | 0.0086 | 120.93 | 87.85M |
TIDMDXRX
RNS Number : 2784I
Diaceutics PLC
10 December 2020
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) (i) 1a. Identity of the issuer or the Diaceutics Plc underlying issuer of existing shares to which voting rights are attached (ii) : --------------------------------------------------------- 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer ---- 2. Reason for the notification (please mark the appropriate box or boxes with an "X") An acquisition or disposal of voting rights X ---- An acquisition or disposal of financial instruments ---- An event changing the breakdown of voting rights ---- Other (please specify)(iii) : ---- 3. Details of person subject to the notification obligation (iv) Name Danske Bank A/S City and country of registered office DK - 1092 Copenhagen (if applicable) 4. Full name of shareholder(s) (if different from 3.) (v) Name DANSKE INVEST MANAGEMENT COMPANY (SOCIÉTE ANONYME)/DANSKE INVEST FCP LUXEMBOURG DANSKE INVEST FUND MANAGEMENT LTD./DANSKE INVEST FINLAND PROXY VOTES SUPPLIED BY INVESTERINGSFORENINGEN DANSKE INVEST --------------------------------------------------------- City and country of registered office (if applicable) --------------------------------------------------------- 5. Date on which the threshold was 09-12-2020 crossed or reached (vi) : --------------------------------------------------------- 6. Date on which issuer notified (DD/MM/YYYY): 10-12-2020 --------------------------------------------------------- 7. Total positions of person(s) subject to the notification obligation 4.77109 % of voting % of voting rights Total of both Total number rights attached through financial in % (8.A + of voting rights to shares (total instruments 8.B) of issuer (vii) of 8. A) (total of 8.B 1 + 8.B 2) ------------------ ---------------------- ------------------------ ---------------------- Resulting situation on the date on which threshold was crossed or reached 2.93 2.93 84,068,923.00 ------------------ ---------------------- ------------------------ ---------------------- Position of previous notification (if applicable) 3.10 3.10 ------------------ ---------------------- ------------------------ ---------------------- 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached (viii) A: Voting rights attached to shares Class/type of Number of voting rights % of voting rights shares (ix) ISIN code (if possible) Direct Indirect Direct Indirect (Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive 2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC) (DTR5.1) (DTR5.2.1) (DTR5.2.1) -------------------------- GB00BJQTGV64 2,459,771.00 2.93 ---------------------- -------------------------- ------------------------- --------------------- SUBTOTAL 8. A 2,459,771.00 2.93 -------------------------------------------------- ------------------------------------------------ B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period rights that may rights instrument (x) (xi) be acquired if the instrument is exercised/converted. ----------- ------------------------------ -------------------------------- --------------------- SUBTOTAL 8. B 1 ------------------------------ -------------------------------- --------------------- B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Type of Expiration Exercise/ Physical or Number of % of voting financial date (x) Conversion cash voting rights rights instrument Period (xi) settlement (xii) ---------------- -------------------- -------------------- -------------------- SUBTOTAL 8.B.2 -------------------- -------------------- 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (xiii) Full chain of controlled undertakings through which the voting rights X and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (xiv) (please add additional rows as necessary) Name (xv) % of voting rights % of voting rights Total of both if if it equals or through financial it equals or is is higher than the instruments if it higher than the notifiable threshold equals or is higher notifiable threshold than the notifiable threshold ---------------------- ---------------------- ------------------------ Danske Invest FCP Luxembourg 13, rue Edward Steichen L-2540 Luxembourg - A mutual fund under management of Danske Invest Management Company (Société Anonyme) 13, rue Edward Steichen L-2540 Luxembourg - a subsidiary 100% owned by Danske Bank International S.A, 13, rue Edward Steichen L-2540 Luxembourg - a subsidiary 100% owned by Danske Bank A/S ---------------------- ---------------------- ------------------------ Danske Invest Finland Hiililaiturinkuja 2, P.O. Box 1553, FIN-00180 Helsinki Finland - a mutual fund under management of Danske Invest Fund Management Ltd. Hiililaiturinkuja 2, P.O. Box 1553, FIN-00180 Helsinki Finland - a subsidiary 100% owned by Danske Bank plc Hiililaiturinkuja 2, P.O. Box 1568 00075 Danske Bank, Finland - a subsidiary 100% owned by Danske Bank A/S ---------------------- ---------------------- ------------------------ Proxy shares given to Danske Capital, a division of Danske
Bank A/S (so no separate legal identity) by: lnvesteringsforeningen Danske Invest Parallelvej 17 DK-2800 Kgs. Lyngby Denmark ---------------------- ---------------------- ------------------------ 10. In case of proxy voting, please identify: Name of the proxy holder DANSKE Capital, a division of Danske Bank A/S ------------------------------------------------ The number and % of voting rights Danske Invest Europa Small cap held (1,012,694.00 shs/votings rights = 1.20%) Danske Invest Europa Small cap AKK (95,917.00 shs/votings rights = 0.11%) ------------------------------------------------ The date until which the voting rights No set expiry date will be held ------------------------------------------------ 11. Additional information (xvi) Place of completion DK - 1092 Copenhagen K Date of completion 10-12-2020 -----------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLEBLFFBLLBFBV
(END) Dow Jones Newswires
December 10, 2020 10:10 ET (15:10 GMT)
1 Year Diaceutics Chart |
1 Month Diaceutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions